I think it is reasonable but of course not the only possible outcome...there is the fact the new boss bought $150k of shares on market recently and took the CEO gig. Perhaps the correct interpretation of that is, despite a likelihood of the next quarter or two being under, the long term is rosier? I can't imagine he'd take the gig or waste cash if he thought it was a lost cause....but perhaps I am giving too much credit.
If guidance is missed or costs show a rise then I think you will find not all has been baked in. If this happens, we will be back to in the 20's or 30's imo unless there is a very good and credible explanation on how it will be resolved.
- Forums
- ASX - By Stock
- TIE
- moving time?
moving time?, page-147
-
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TIE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online